Autocrine stimulation of motility in SBC-5 human lung carcinoma cells by a two-kringle variant of HGF

Cancer Lett. 1994 Aug 15;83(1-2):235-43. doi: 10.1016/0304-3835(94)90325-5.

Abstract

Hepatocyte growth factor (HGF), a ligand for the c-met protooncogene product, is a pleiotropic cytokine which elicits mitogenic, motogenic and morphogenic activities. Among various human lung carcinoma cells, we found that SBC-5 small cell lung carcinoma cells simultaneously expressed the c-Met/HGF receptor and a smaller variant-type of HGF composed of N-terminal two-kringle domains, without expressing authentic heterodimeric HGF. The addition of anti-HGF antibodies to cultures of SBC-5 cells specifically inhibited spreading and motility of the cells without affecting growth, and the conditioned medium of SBC-5 cells also induced scattering of other lineage lung carcinoma. Thus, simultaneous expression of the unique smaller variant HGF and its receptor, c-Met, in SBC-5 cells suggests the involvement of a smaller variant HGF in the development or progression of the lung carcinoma cells, through an autocrine mechanism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma / physiopathology*
  • Cell Movement
  • Gene Expression
  • Hepatocyte Growth Factor / physiology*
  • Humans
  • In Vitro Techniques
  • Kringles
  • Lung Neoplasms / physiopathology*
  • Proto-Oncogene Proteins c-met
  • RNA, Messenger / genetics
  • RNA, Neoplasm / genetics
  • Receptor Protein-Tyrosine Kinases / physiology
  • Structure-Activity Relationship
  • Tumor Cells, Cultured

Substances

  • RNA, Messenger
  • RNA, Neoplasm
  • Hepatocyte Growth Factor
  • Proto-Oncogene Proteins c-met
  • Receptor Protein-Tyrosine Kinases